T.N. SEMENOVA¹ , E.V. GUZANOVA¹, T.A. SOROKINA¹

 ¹ FSBEI HE Privolzhskiy Research Medical University MOH Russia, Nizhny Novgorod, Russian Federation

  Contact details:

Semenova T.N. – postgraduate student of the Department of Neurology, Neurosurgery and Medical Genetics

Address: 10/1 Minin and Pozharskiy square, Nizhny Novgorod, Russian Federation, 603005, tel.: +7 (831) 438-95-67, e-mail: neurotmdoc@gmail.com

The review presents the results of analysis of the current literature on speech disorders in patients with neurodegenerative diseases. The patterns of speech disorders developing in primary progressive aphasia, Alzheimer’s disease, frontal-temporal dementia, Parkinson’s disease, and cortical-basal degeneration are described. The methods of diagnostics of speech disorders, including the use of modern digital systems are analyzed, which may be useful for identifying the features of afatic disorders under various forms of neurodegenerations. It is shown that the detailed analysis of speech function can lead to the discovery of sensitive methods for early diagnosis of neurodegenerative processes in the brain and the timely administration of medicine, conducting personalized rehabilitation for such patients.

Key words: speech disorders, aphasia, neurodegenerative diseases, diagnostic of speech disorders.

REFERENCES

1. Sweeney M., Montagne A., Sagare A. Vascular dysfunction-The disregarded partner of Alzheimer’s disease. Alzheimers Dement, 2019, vol. 15, no. 1, rr. 158–167.
2. Prince M., Bryce R., Albanese E. et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer’s Demen, 2013, vol. 9, no. 1, pp. 63–75.
3. Vasenina E.E., Levin O.S. Primary progressive aphasia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2014, vol. 114, no. 6, pp. 3–12 (in Russ.).
4. Kirshner H.S. Primary progressive aphasia and Alzheimer’s disease: brief history, recent evidence . Curr Neurol Neurosci Rep, 2012, vol. 12, no. 6, rr. 709–714.
5. Posner H., Curiel R., Edgar C. et al. Outcomes assessment in clinical trials of Alzheimer’s disease and its precursors: readying for short-term and long-term clinical trial needs. Innov. Clin. Neurosci, 2017, vol. 14, no. 1, r. 22.
6. Mesulam M., Rogalski E., Wieneke C. et al. Primary progressive aphasia and the evolving neurology of the language network. Nat Rev Neurol, 2014, vol. 10, no. 10, rr. 554–569. DOI: 10.1038/nrneurol.2014.159
7. Kertesz A., Harciarek M. Primary progressive aphasia. Scand J. Psychol, 2014, vol. 55, no. 3, rr. 191–201.
8. Mesulam M., Weintraub S., Rogalski E. et al. Asymmetry and heterogeneity of Alzheimer’s and frontotemporal pathology in primary progressive aphasia. Brain, 2014, vol. 137, no. 4, rr. 1176–1192. DOI: 10.1093/brain/awu024
9. Gorno-Tempini M., Hillis A., Weintraub S. et al. Classification of primary progressive aphasia and its variants. Neurology, 2011, no. 76, rr. 1006–1014.
10. Bisenius S., Neumann J., Schroeter M. Validating new diagnostic imaging criteria for primary progressive aphasia via anatomical likelihood estimation meta-analyses. Eur J Neurol, 2016, vol. 23, no. 4, rr. 704–712.
11. Kobayashi R., Hayashi H., Kawakatsu S. [F-18] THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review. BMC neurology, 2018, vol. 18, no. 109, pp. 109–116.
12. Basilakos A. Contemporary Approaches to the Management of Post-stroke Apraxia of Speech. Seminars in speech and language, 2018, vol. 39, suppl. 1, rr. 25–36.
13. Utianski R., Whitwell J., Schwarz C. Tau-PET imaging with [18F] AV-1451 in primary progressive apraxia of speech. Cortex, 2018, vol. 99, rr. 358–374.
14. Catricala E., Della R., Plebani V. et al. Semantic feature degradation and naming performance. Evidence from neurodegenerative disorders. Brain Lang, 2015, vol. 147, rr. 58–65.
15. Drummond C., Coutinho G., Paz Fonseca R. et al. Deficits in narrative discourse elicited by visual stimuli are already present in patients with Mild Cognitive Impairment. Front. Aging Neurosci, 2015, vol. 7, no. 96, rr. 33–48. DOI: 10.3389/fnagi.2015.00096
16. Delbeuck X., Debachy B., Pasquier F., Moroni C. Action and noun fluency testing to distinguish between Alzheimer’s disease and dementia with Lewy bodies. J. Clin. Exp. Neuropsychol, 2013, vol. 35, rr. 259–268. DOI: 10.1080/13803395.2013.763907
17. Ash S., Xie S., Gross R. et al. The organization and anatomy of narrative comprehension and expression in Lewy body spectrum disorders. Neuropsychology, 2012, vol. 26, rr. 368. DOI: 10.1037/a0027115
18. Mendez M., Carr A., Paholpak P. Psychotic-Like Speech in Frontotemporal Dementia. J. Neuropsychiatry Clin Neurosci, 2017, vol. 29, no. 2, rr. 183–185.
19. Assal F., Ghika J. Language capacities in dementia. Swiss Arch. Neurol. Psychiatry, 2013, vol. 164, rr. 280–285.
20. Dashtipour K., Tafreshi A., Lee J. Speech disorders in Parkinson’s disease: pathophysiology, medical management and surgical approaches. Neurodegenerative disease management, 2018, vol. 8, suppl. 5, rr. 337–348.
21. Oliveira L., Barcellos I., Teive H. Cognitive dysfunction in corticobasal degeneration. Munhoz RPArq Neuropsiquiatr, 2017, vol. 75, no. 8, rr. 570–579.
22. Fraser K., Fors K., Kokkinakis D. Multilingual word embeddings for the assessment of narrative speech in mild cognitive impairment. Computer Speech & Language, 2019, vol. 53, rr. 121–139.
23. Ash S., McMillan C., Gross R. et al. Impairments of speech fluency in Lewy body spectrum disorder. Brain Lang, 2012, vol. 120, rr. 290–302.
24. De Lira J., Ortiz K., Campanha A. Microlinguistic aspects of the oral narrative in patients with Alzheimer’s disease. Int. Psychogeriatr, 2011, vol. 23, rr. 404–412.
25. Lopez-de-Ipina K., Alonso J., Travieso C. et al. On the selection of non-invasive methods based on speech analysis oriented to automatic Alzheimer disease diagnosis. Sensors, 2013, vol. 13, rr. 6730–6745.
26. Fraser K., Meltzer J., Rudzicz F. Linguistic features identify Alzheimer’s disease in narrative speech. J. Alz. Dis, 2015, vol. 49, rr. 407–422.
27. Konig A., Satt A., Sorin A. et al. Automatic speech analysis for the assessment of patients with predementia and Alzheimer’s disease Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring. Cognitive & Behavioral Assessment, 2015, vol. 1, no. 1, pp. 112–124.
28. Elsey C., Drew P., Jones D. et al. Towards diagnostic conversational profiles of patients presenting with dementia or functional memory disorders to memory clinics. Pat. Edu. Counsel, 2015, vol. 98, rr. 1071–1077.
29. Toth L., Gosztolya G., Vincze V. et al. Automatic detection of mild cognitive impairment from spontaneous speech using ASR. 16th Annual Conference of the International-Speech-Communication-Association, 2015, vol. 1, no. 5, rr. 2694–2698.
30. Asgari M., Kaye J., Dodge H. Predicting mild cognitive impairment from spontaneous spoken utterances. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 2017, vol. 3, no. 2, pp. 219–228.
31. Toledo C., Aluisio S., Dos Santos L. Analysis of macrolinguistic aspects of narratives from individuals with Alzheimer’s disease, mild cognitive impairment, and no cognitive impairment. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2018, vol. 10, rr. 31–40.
32. Gosztolya G., Vincze V., Toth L. Identifying Mild Cognitive Impairment and mild Alzheimer’s disease based on spontaneous speech using ASR and linguistic features. Computer speech and language, 2019, vol. 53, rr. 181–197.
33. Rusz J., Hlavnicka J., Tykalova T. Smartphone Allows Capture of Speech Abnormalities Associated With High Risk of Developing Parkinson’s Disease. IEEE transactions on neural systems and rehabilitation engineering, 2018, vol. 26, no. 8, rr. 1495–1507.